-
Demant to Acquire KIND Group, EU’s Largest Independent Hearing Care Network
Denmark-based hearing healthcare company Demant has announced the acquisition of Germany's KIND Group, a major hearing aid retailer, in a €700 million deal. This marks Demant’s largest retail acquisition to date and will expand its global network of hearing care clinics to over 4,500 locations, reinforcing its presence in Central Europe. KIND, with approximately 650-700 retail clinics across Germany and several other countries, is one of the last large-scale independent hearing aid chains in ...
-
Do You Need Your Hearing Aids to Drive?
This article shares the author's experience renewing their driver’s license and reflecting on whether hearing aids are necessary for driving. While they determined that most driving cues are visual and hearing aids are not strictly required, they still chose to wear them while driving for added safety. The author also discussed challenges of driving with hearing loss, such as communication during traffic stops, and shared tips like minimizing distractions and using special visor cards to commun...
-
Invisible Eargo 7 OTC Hearing Aids Compete with Premium Prescription Products
Eargo has positioned itself as a premium player in the over-the-counter (OTC) hearing aid market with its Eargo 7, which offers advanced features like a new sound-processing algorithm, IPX7 water resistance, and up to 16 hours of battery life. Unlike many OTC competitors, Eargo focuses on competing with high-end prescription hearing aids by combining cutting-edge technology with extensive professional remote support from licensed audiologists. The company emphasizes its invisible, completely-in-c...
-
Eargo, Hearx, and Lexie Hearing Merge to form LXE Hearing
Two leading over-the-counter (OTC) hearing aid companies, Eargo and hearX (owner of Lexie Hearing), have merged to form **LXE Hearing**, with a $100 million investment from Patient Square Capital. This merger is the most significant consolidation in the OTC hearing aid market since the FDA approved non-prescription sales in 2022. LXE Hearing will continue to market both Eargo and Lexie as separate brands, leveraging their combined 25 years of experience in the industry. The funding aims to accele...
-
Eargo Launches Eargo 8 with Smart Sound Adjust, Improved Self-fitting System, and Innovative Device S
Eargo has introduced its latest over-the-counter (OTC) hearing aid, the Eargo 8, as a significant advancement in hearing care. Designed to address challenges in invisibility, user-friendliness, and clinical performance, the Eargo 8 features Smart Sound Adjust for dynamic noise adaptation, an improved self-fitting system, and Device Scan for detecting wax blockages. Priced at $2,699, it complements Eargo's existing lineup of products and builds on advancements from its merger with LXE Hearing. The...
-
Eargo to Be Fully Acquired by Patient Square Capital and Become a Private Company
Eargo, Inc. (Nasdaq: EAR), a leading manufacturer of over-the-counter (OTC) hearing aids, has entered into a definitive merger agreement with Patient Square Capital, its majority shareholder since November 2022, under which Patient Square will acquire all outstanding common stock shares not currently owned by it for $2.55 per share in cash. This represents a premium of approximately 52% over Eargo's closing price on October 27, 2023. The transaction has been recommended by a special committee of ...
Blog
Copyright © 2025 Sengdong All Rights Reserved